Psychedelics: Rewiring Mental Health Care
Exacerbated by COVID-19 and exemplified by the 45 million Americans with a mental illness, mental health care in the U.S. is insufficient. In recent years, medical professionals have turned to natural medicine for an answer - and they might have found it in psilocybin, the psychoactive substance found in magic mushrooms. Designated as “breakthrough therapy” by the FDA, psilocybin therapy has the potential to reinvent the paradigm for treating psychiatric disorders like addiction, PTSD and depression. Listen to experts in all things mushroom and psychiatry examine the potential of psilocybin mushrooms in revolutionizing mental healthcare. They will discuss ongoing clinical trials, recent medical discoveries and how the fungi may be part of the solution to America’s mental health crisis.
Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.
Alan Davis PhD
Johns Hopkins University
Dr Michael Hart
Readytogo Clinic
Ronan Levy
Field Trip Health
Rachel Yehuda
Center for Psychedelic Psychotherapy and Trauma Research